u/Soft_Ant4357 · 391d agono track record yet
“holding a small position with a $.30 average”
PSCA - A Biopharmaceutical - The Next Runner?
Processa Pharmaceuticals is a small-cap biopharmaceutical with pipeline catalysts in 2025-2026, including Phase 2/3 NGC-Gemcitabine trials, FDA discussions on PCS499, and investor conferences. The company has sufficient cash runway (7-9 months) to reach key milestones without near-term dilution threats, positioning it as a potential runner for early-stage biotech investors.
At post $9.00live price unavailable
1d+33.1%
3d+5.3%
1w+10.0%
1m-12.2%
3m-64.1%
6m-69.2%
1y-84.2%